This tetrapeptide reduces redness of face caused by an inflammatory reaction.
Mechanism of action
It inhibits the inflammatory effect of LL-37 through reducing the release of interleukins (IL-6 and IL-8), caused by overactivation of LL-37. It also has a photoprotective effect that reduces cell damage and the harmful effects of skin inflammation.
Adverse effects of inflammation: redness, dilated blood vessels and hyperpigmentation, are visibly reduced. The red areas are less numerous and large and its intensity is weaked. The skin is more uniform and less marked.
Lipotec develops active ingredients for the personal care industry and supplies them to leading cosmetic product manufacturers and brand owners worldwide.
The information contained in Lipotec's intranet is exclusively addressed to personal care industry professionals and access to specific data will be granted according to user profile (customers, distributors, consultants, media...).